United Health Products, Inc. (UEEC)
USD 0.27
(6.8%)
USD 0.27
(6.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.5 Million USD | -73.65% |
| 2022 | -1.6 Million USD | 95.27% |
| 2021 | -748.54 Thousand USD | -98.65% |
| 2020 | -862.74 Thousand USD | -143.66% |
| 2019 | -6.09 Million USD | -156.74% |
| 2018 | -5.4 Million USD | -343.95% |
| 2017 | -534.66 Thousand USD | -3.32% |
| 2016 | -517.47 Thousand USD | 79.96% |
| 2015 | -2.58 Million USD | -26.47% |
| 2014 | -2.04 Million USD | -67.85% |
| 2013 | -1.21 Million USD | -1036.92% |
| 2012 | -107.01 Thousand USD | 91.21% |
| 2011 | -1.21 Million USD | 55.15% |
| 2010 | -2.53 Million USD | -258.12% |
| 2009 | -796.32 Thousand USD | -173.95% |
| 2008 | -276.68 Thousand USD | -21.21% |
| 2007 | -228.26 Thousand USD | -19.41% |
| 2006 | -191.16 Thousand USD | -1133.21% |
| 2005 | -15.5 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -423.73 Thousand USD | 4.82% |
| 2024 Q2 | -403.94 Thousand USD | 4.67% |
| 2023 FY | - USD | -73.6% |
| 2023 Q1 | -1.05 Million USD | -90.56% |
| 2023 Q2 | -474.44 Thousand USD | 54.94% |
| 2023 Q3 | -449.09 Thousand USD | 5.34% |
| 2023 Q4 | -445.19 Thousand USD | 0.87% |
| 2022 Q4 | -552.55 Thousand USD | -163.89% |
| 2022 Q1 | -953.48 Thousand USD | -24.36% |
| 2022 Q2 | -753.78 Thousand USD | 20.94% |
| 2022 Q3 | 864.81 Thousand USD | 214.73% |
| 2022 FY | - USD | 95.27% |
| 2021 Q1 | -26.7 Million USD | -457.79% |
| 2021 FY | - USD | -98.65% |
| 2021 Q4 | -766.69 Thousand USD | -5.84% |
| 2021 Q3 | -724.41 Thousand USD | 44.28% |
| 2021 Q2 | -1.3 Million USD | 95.13% |
| 2020 FY | - USD | -143.66% |
| 2020 Q4 | -4.78 Million USD | 47.42% |
| 2020 Q3 | -9.1 Million USD | -1305.48% |
| 2020 Q2 | -647.87 Thousand USD | -3.86% |
| 2020 Q1 | -623.8 Thousand USD | 70.51% |
| 2019 FY | - USD | -156.74% |
| 2019 Q1 | -2.98 Million USD | -324.28% |
| 2019 Q4 | -2.11 Million USD | -384.45% |
| 2019 Q3 | -436.66 Thousand USD | 21.48% |
| 2019 Q2 | -556.11 Thousand USD | 81.38% |
| 2018 FY | - USD | -343.95% |
| 2018 Q4 | -703.75 Thousand USD | -76.92% |
| 2018 Q1 | 3.27 Million USD | 709.82% |
| 2018 Q2 | -918.43 Thousand USD | -128.04% |
| 2018 Q3 | -397.79 Thousand USD | 56.69% |
| 2017 Q4 | -537.03 Thousand USD | -296.31% |
| 2017 Q3 | -135.5 Thousand USD | -24.58% |
| 2017 Q2 | -108.76 Thousand USD | -275.45% |
| 2017 FY | - USD | -3.32% |
| 2017 Q1 | 61.99 Thousand USD | 135.14% |
| 2016 Q1 | -111.78 Thousand USD | 76.15% |
| 2016 Q3 | -170.78 Thousand USD | -192.03% |
| 2016 Q4 | -176.41 Thousand USD | -3.3% |
| 2016 FY | - USD | 79.96% |
| 2016 Q2 | -58.48 Thousand USD | 47.69% |
| 2015 Q1 | -1.57 Million USD | 6.0% |
| 2015 FY | - USD | -26.47% |
| 2015 Q4 | -468.66 Thousand USD | -18.77% |
| 2015 Q3 | -394.6 Thousand USD | -166.72% |
| 2015 Q2 | -147.94 Thousand USD | 90.59% |
| 2014 Q2 | -173.5 Thousand USD | -39.71% |
| 2014 Q4 | -1.67 Million USD | -2198.59% |
| 2014 Q3 | -72.73 Thousand USD | 58.08% |
| 2014 FY | - USD | -67.85% |
| 2014 Q1 | -124.18 Thousand USD | 63.06% |
| 2013 Q2 | -60.91 Thousand USD | -304.64% |
| 2013 Q1 | -15.05 Thousand USD | 72.66% |
| 2013 Q4 | -336.16 Thousand USD | 58.22% |
| 2013 Q3 | -804.57 Thousand USD | -1220.91% |
| 2013 FY | - USD | -1036.92% |
| 2012 Q3 | -15 Thousand USD | 10.47% |
| 2012 FY | - USD | 91.21% |
| 2012 Q4 | -55.05 Thousand USD | -266.88% |
| 2012 Q2 | -16.75 Thousand USD | 17.05% |
| 2012 Q1 | -20.2 Thousand USD | 93.55% |
| 2011 Q3 | -165.25 Thousand USD | 22.26% |
| 2011 FY | - USD | 55.15% |
| 2011 Q1 | -526.6 Thousand USD | -23.14% |
| 2011 Q2 | -212.56 Thousand USD | 59.63% |
| 2011 Q4 | -312.98 Thousand USD | -89.4% |
| 2010 Q4 | -427.63 Thousand USD | 58.6% |
| 2010 Q3 | -1.03 Million USD | 11.68% |
| 2010 Q2 | -1.16 Million USD | -1354.4% |
| 2010 Q1 | -80.42 Thousand USD | 87.16% |
| 2010 FY | - USD | -258.12% |
| 2009 Q1 | -80.76 Thousand USD | 10.12% |
| 2009 FY | - USD | -173.95% |
| 2009 Q4 | -626.21 Thousand USD | -249.69% |
| 2009 Q3 | -179.07 Thousand USD | -39.42% |
| 2009 Q2 | -128.44 Thousand USD | -59.04% |
| 2008 Q4 | -89.85 Thousand USD | 29.57% |
| 2008 Q2 | -26.45 Thousand USD | 2.92% |
| 2008 Q3 | -127.57 Thousand USD | -382.34% |
| 2008 Q1 | -27.24 Thousand USD | 26.39% |
| 2008 FY | - USD | -21.21% |
| 2007 Q2 | -70.16 Thousand USD | 10.79% |
| 2007 FY | - USD | -19.41% |
| 2007 Q3 | -55.38 Thousand USD | 21.06% |
| 2007 Q1 | -78.65 Thousand USD | -74.03% |
| 2007 Q4 | -37.01 Thousand USD | 33.18% |
| 2006 Q1 | -20.95 Thousand USD | -184.95% |
| 2006 Q3 | -61.71 Thousand USD | 2.25% |
| 2006 Q4 | -45.19 Thousand USD | 26.77% |
| 2006 FY | - USD | -1133.21% |
| 2006 Q2 | -63.13 Thousand USD | -201.22% |
| 2005 Q4 | -7355.00 USD | -45.3% |
| 2005 Q3 | -5062.00 USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -159.578% |
| Ansell Limited | 209.86 Million USD | 101.192% |
| Ansell Limited | 206.3 Million USD | 101.213% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 105.841% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | -53.987% |
| Psykey, Inc. | -1.29 Million USD | -93.176% |
| ConvaTec Group Plc | 455.5 Million USD | 100.549% |
| ConvaTec Group Plc | 455.5 Million USD | 100.549% |
| Encision Inc. | -544.19 Thousand USD | -359.801% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1664.483% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -2176.188% |
| Innovative MedTech Inc. | -7.67 Million USD | 67.393% |
| LifePoint, Inc. | -14.2 Million USD | 82.381% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 59.557% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -669.912% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -1062.555% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -516.637% |
| SmileDirectClub, Inc. | -186.13 Million USD | 98.656% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.559% |
| SheerVision, Inc. | -110.53 Thousand USD | -2163.812% |
| Vasamed, Inc. | -4.57 Million USD | 45.3% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | -10.681% |
| Yubo International Biotech Limited | -1.17 Million USD | -112.469% |